Black SB - Search Results

1

Cost-effectiveness of respiratory syncytial virus prophylaxis among preterm infants.

Joffe S, Ray GT, Escobar GJ, Black SB, Lieu TA. Joffe S, et al. Among authors: black sb. Pediatrics. 1999 Sep;104(3 Pt 1):419-27. doi: 10.1542/peds.104.3.419. Pediatrics. 1999. PMID: 10469764

2

Cost-effectiveness of varicella serotesting versus presumptive vaccination of school-age children and adolescents.

Lieu TA, Finkler LJ, Sorel ME, Black SB, Shinefield HR. Lieu TA, et al. Among authors: black sb. Pediatrics. 1995 May;95(5):632-8. Pediatrics. 1995. PMID: 7724297

3

Rehospitalization for respiratory syncytial virus among premature infants.

Joffe S, Escobar GJ, Black SB, Armstrong MA, Lieu TA. Joffe S, et al. Among authors: black sb. Pediatrics. 1999 Oct;104(4 Pt 1):894-9. doi: 10.1542/peds.104.4.894. Pediatrics. 1999. PMID: 10506231

4

Assessing costs and cost effectiveness of pneumococcal disease and vaccination within Kaiser Permanente.

Black S, Lieu TA, Ray GT, Capra A, Shinefield HR. Black S, et al. Vaccine. 2000 Dec 8;19 Suppl 1:S83-6. doi: 10.1016/s0264-410x(00)00284-x. Vaccine. 2000. PMID: 11163469 Clinical Trial.

5

Cost-effectiveness of a routine varicella vaccination program for US children.

Lieu TA, Cochi SL, Black SB, Halloran ME, Shinefield HR, Holmes SJ, Wharton M, Washington AE. Lieu TA, et al. Among authors: black sb. JAMA. 1994 Feb 2;271(5):375-81. JAMA. 1994. PMID: 8283587

6

Effectiveness and cost-effectiveness of letters, automated telephone messages, or both for underimmunized children in a health maintenance organization.

Lieu TA, Capra AM, Makol J, Black SB, Shinefield HR. Lieu TA, et al. Among authors: black sb. Pediatrics. 1998 Apr;101(4):E3. doi: 10.1542/peds.101.4.e3. Pediatrics. 1998. PMID: 9521970 Clinical Trial.

7

Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children.

Lieu TA, Ray GT, Black SB, Butler JC, Klein JO, Breiman RF, Miller MA, Shinefield HR. Lieu TA, et al. Among authors: black sb. JAMA. 2000 Mar 15;283(11):1460-8. doi: 10.1001/jama.283.11.1460. JAMA. 2000. PMID: 10732936

8

Observed costs and health care use of children in a randomized controlled trial of pneumococcal conjugate vaccine.

Ray GT, Butler JC, Black SB, Shinefield HR, Fireman BH, Lieu TA. Ray GT, et al. Among authors: black sb. Pediatr Infect Dis J. 2002 May;21(5):361-5. doi: 10.1097/00006454-200205000-00002. Pediatr Infect Dis J. 2002. PMID: 12150168 Clinical Trial.

9

Risk factors for developing apnea after immunization in the neonatal intensive care unit.

Klein NP, Massolo ML, Greene J, Dekker CL, Black S, Escobar GJ; Vaccine Safety Datalink. Klein NP, et al. Pediatrics. 2008 Mar;121(3):463-9. doi: 10.1542/peds.2007-1462. Pediatrics. 2008. PMID: 18310193

10

Cost-effectiveness of pneumococcal vaccine.

Lieu T, Ray GT, Black S, Shinefield H, Butler J, Miller M. Lieu T, et al. JAMA. 2000 Jul 26;284(4):440-1. JAMA. 2000. PMID: 10904501 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124 results

Search Page

Filters